- Lymphoma, CLL, MM, MPN, MDS, MRD, ADs, Aplasia, Acute Leukemia
- GVHD
- Complications
- New drugs, gene therapy, stem cell topics, paediatrics
Lymphoma, CLL, MM, MPN, MDS, MRD, ADs, Aplasia, Acute Leukemia
- Oral session 1: Lymphoma, CLL, and multiple myeloma
- Oral session 2: Inborn errors, immunodeficiency
- Oral session 3: Various diseases: myeloproliferative neoplasm and MDS
- Oral session 7: MRD, chimerism, relapse, and immune reconstitution
- Oral session 11: Aplastic anemia, autoimmune diseases
- Oral session 12: Acute leukemia
GVHD
- Oral session 10: GVHD I, clinical
- Oral session 14: GVHD II, clinical and preclinical
Complications
- Oral session 4: Infectious complications I
- Oral session 5: Non-infectious early and late complications
- Oral session 6: Infectious complications II, COVID
- Oral session 19: Non-infectious late effects and complications
New drugs, gene therapy, stem cell topics, paediatrics
- Oral session 15: New drugs, gene therapy, and experimental transplantation
- Oral session 16: Conditioning
- Oral session 17: Stem cell donor, stem cell source, mobilisation and collection
- Oral session 18: Paediatrics